Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Avalo Therapeutics Inc.

    NASDAQ: AVTX · Real-Time Price · USD
    9.86
    0.49 (5.23%)
    At close: Aug 22, 2025, 1:46 PM

    Avalo Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 441K 1.92M 18.05M 5.4M
    Cost of Revenue
    		 -366K 1.28M 3.43M 1.49M
    Gross Profit
    		 807K 640K 14.62M 3.91M
    Operating Income
    		 -68.51M -27.35M -37.44M -82.13M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -35.02M -31.53M -41.63M -84.55M
    Net Income
    		 -35.13M -31.54M -41.66M -84.35M
    Selling & General & Admin
    		 17.24M 10.3M 20.71M 24.66M
    Research & Development
    		 52.08M 13.78M 31.31M 59.84M
    Other Expenses
    		 n/a 3.91M 38K 1.55M
    Operating Expenses
    		 69.32M 27.99M 52.06M 86.04M
    Interest Expense
    		 n/a 3.42M 4.17M 2.39M
    Selling & Marketing Expenses
    		 789K 33K 76K 2.83M
    Cost & Expenses
    		 68.95M 29.27M 55.49M 87.53M
    Income Tax Expense
    		 114K 14K 28K -196K
    Shares Outstanding (Basic)
    		 8.13M 277.73K 39.2K 36.19K
    Shares Outstanding (Diluted)
    		 10.78M 277.73K 39.2K 36.19K
    EPS (Basic)
    		 -4.32 -113.58 -1.06K -2.33K
    EPS (Diluted)
    		 -3.26 -113.58 -1.06K -2.33K
    EBITDA
    		 -68.34M -23.29M -37.29M -80.5M
    EBIT
    		 -68.51M -23.44M -37.46M -82.15M
    Depreciation & Amortization
    		 169K 158K 166K 1.66M

    Add to Watchlist